Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2026PharmaceuticalsOpen Access

Beyond Weight Loss and Glycemic Control: Molecular Mechanisms and Hypothesis-Generating Therapeutic Potential of Incretin-Based Therapies Against Peritoneal Fibrosis in Peritoneal Dialysis

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYi‐Chen LiNational Cheng Kung University HospitalJHJui-Ting HsuAsia UniversityCFChung-Ming FuChang Gung University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/6ab60ebd406bf401c146729chttps://doi.org/10.3390/ph19101502
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits2025 · 83 citations
  2. 2Pathophysiological Mechanisms of Peritoneal Fibrosis and Peritoneal Membrane Dysfunction in Peritoneal Dialysis2024 · 46 citations
  3. 3Pathophysiological Changes to the Peritoneal Membrane during PD-Related Peritonitis: The Role of Mesothelial Cells2012 · 124 citations
  4. 4Peritoneal Glucose Exposure and Changes in Membrane Solute Transport with Time on Peritoneal Dialysis2001 · 393 citations
  5. 5Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension2019 · 263 citations